Clinical trial

Docetaxel Compared With Observation in Treating Patients Who Have Undergone…

NCT00376792 · Scandinavian Prostate Cancer Group, Other · Unknown status

Key facts

NCT number NCT00376792
Title Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
Official title An Open Randomized Phase III Trial of Six Cycles of Docetaxel Versus Surveillance After Radical Prostatectomy in High Grade Prostate Cancer Patients With Margin Positive T2 or T3 Tumours
Lead sponsor Scandinavian Prostate Cancer Group, Other
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Prostate Cancer
Intervention type Drug, Other, Procedure
Interventions docetaxel, active surveillance, adjuvant therapy
Enrollment 396
Start date Oct 1, 2005
Primary completion Dec 1, 2012
First posted Sep 15, 2006
Last update posted Aug 26, 2013
Countries Denmark, Finland, Iceland, Norway, Sweden

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies